Metabolically, IDH1 converts isocitrate to α-ketoglutarate, however, mutations of IDH1/2 are frequent in cancer, and lead to conversion of α-ketoglutarate to 2-hydroxyglutarate (2-HG) (Liu et al., 2023). The gene discussed is IDH1; the disease is cancer.